D18.03 Hemangioma of intra-abdominal structures

✓ Billable ICD-10-CM 2026
Open D18.03 in Web App →

The ICD-10-CM code for Hemangioma of intra-abdominal structures is D18.03 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D10-D36: Benign neoplasms, except benign neuroendocrine tumors (D10-D36)
Category D18
8 codes (6 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D18.03:

  • Hemangioma › intra-abdominal
  • Glomangioma › intra-abdominal
  • Glomangiomyoma › intra-abdominal
  • Angioma › intra-abdominal
  • Cyst (colloid) (mucous) (simple) (retention) › hemangiomatous › intra-abdominal
  • Angioendothelioma › benign › intra-abdominal
  • Hemangioendothelioma › benign › intra-abdominal
  • Angioma › plexiform › intra-abdominal

U.S. Hospital Utilization

  • An estimated 24,535 U.S. inpatient stays in 2023 included D18.03 among the documented diagnoses.
  • 935 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial